Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jens Blobner
Observed names:
Blobner, Jens,
J Blobner,
J. Blobner
Institutions:
German Cancer Research Center,
German Center for Neurodegenerative Diseases,
LMU Klinikum,
Ludwig-Maximilians-Universität München
Observed institutions:
German Cancer Research Center,
Heidelberg University,
German Center for Neurodegenerative Diseases,
University Hospital Heidelberg,
LMU Klinikum,
Medizinische Fakultät Mannheim,
Deutsches Konsortium für Translationale Krebsforschung,
Ludwig-Maximilians-Universität München
show all 8
ORCID:
0000-0002-8539-8745
Observed ORCID:
0000-0002-8539-8745
OpenAlex ID:
A5012365115
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
2020
·
Katrin Aslan
, Verena Turco
, et al.
·
Nature Communications
·
162
PDF
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas
2022
·
Lukas Bunse
, Anne-Kathleen Rupp
, et al.
·
Neurological Research and Practice
·
45
PDF
Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution
2023
·
Laura M. Bartos
, Sabrina V. Kirchleitner
, et al.
·
Science Advances
·
25
PDF
CAR T-Cells for CNS Lymphoma: Driving into New Terrain?
2021
·
Philipp Karschnia
, Jens Blobner
, et al.
·
Cancers
·
25
PDF
In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer
2023
·
Tao Xu
, Philipp Karschnia
, et al.
·
OncoImmunology
·
22
PDF
In vivo two-photon characterization of tumor-associated macrophages and microglia (TAM/M) and CX3CR1 during different steps of brain metastasis formation from lung cancer
2021
·
Wenlong Zhang
, Philipp Karschnia
, et al.
·
Neoplasia
·
21
PDF
Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma
2023
·
Jens Blobner
, Laura Dengler
, et al.
·
Neuro-Oncology Advances
·
17
PDF
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
2022
·
Jonathan Weller
, Sophie Katzendobler
, et al.
·
Journal of Neuro-Oncology
·
14
PDF
Determinants of long-term survival in patients with IDH-mutant gliomas
2024
·
Sophie Katzendobler
, Sebastian Niedermeyer
, et al.
·
Journal of Neuro-Oncology
·
13
PDF
Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome
2024
·
Laura M Bartos
, Stefanie Quach
, et al.
·
Clinical Cancer Research
·
9
PDF
18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model
2022
·
Laura M. Bartos
, Sabrina V. Kirchleitner
, et al.
·
Frontiers in Medicine
·
9
PDF
Resection of glioma—Feeding the beast?
2022
·
Jens Blobner
, Joerg-Christian Tonn
·
Neuro-Oncology
·
9
PDF
Shunt dependency in supratentorial intraventricular tumors depends on the extent of tumor resection
2023
·
Nico Teske
, Mariana Chiquillo-Domínguez
, et al.
·
Acta Neurochirurgica
·
8
PDF
Subventricular zone involvement is associated with worse outcome in glioma WHO grade 2 depending on molecular markers
2021
·
Philipp Karschnia
, Jonathan Weller
, et al.
·
Scientific Reports
·
8
PDF
Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes
2021
·
Jens Blobner
, Michael Kilian
, et al.
·
Neuro-Oncology Advances
·
8
PDF
PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis
2024
·
Jens Blobner
, Laura Dengler
, et al.
·
Cancer Immunology Immunotherapy
·
5
PDF
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
2022
·
Jonathan Weller
, Sophie Katzendobler
, et al.
·
Research Square
·
2
PDF
Histopathology-verified comparison of FET PET and contrast-enhanced MRI for tumor visualization in glioblastoma.
2026
·
Roman Stuerzl
, Sabrina Viktoria Kirchleitner
, et al.
·
Journal of Clinical Oncology
·
1
Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3
2025
·
Jens Blobner
, Viktoria Ruf
, et al.
·
Journal of Neuro-Oncology
·
1
PDF
10.02 Combined anti-angiogenic treatment to increase intratumoral persistence of CAR T-cells in lung cancer brain metastases
2024
·
C Eberle
, J Blobner
, et al.
·
Oral Presentations
·
1
PDF
Innv-06. Significance of Molecular Diagnostics for Therapeutic Decision-making in Recurrent Glioma
2023
·
Jens Blobner
, Laura Dengler
, et al.
·
Neuro-Oncology
·
1
PDF
Tami-02. Depletion of Intratumoral Tumor-associated Macrophages and Microglia (tam/m) Improves Checkpoint-inhibition Therapy for Brain Metastasis From Lung Cancer
2021
·
Philipp Karschnia
, Tao Xu
, et al.
·
Neuro-Oncology
·
1
PDF
BSCI-08. In vivo two-photon characterization of tumor-associated macrophages and microglia (TAM/M) and CX3CR1 during different steps of brain metastasis formation from lung cancer
2021
·
Wenlong Zhang
, Philipp Karschnia
, et al.
·
Neuro-Oncology Advances
·
1
Biom-15. Subventricular Zone Involvement Is Associated With Worse Outcome in Glioma Who Grade Ii Independent of Molecular Markers
2020
·
Philipp Karschnia
, Jonathan Weller
, et al.
·
Neuro-Oncology
·
1
PDF
Allocation of TSPO-PET signals to cellular and extracellular compartments in dependence of blood-brain barrier disruption in experimental glioblastoma
2026
·
Leonie Hoermann
, Fatma Burcu Seker
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
PDF
Show more works
View as search
Works count:
77
Citation count:
409
H-index:
9
I10-index:
9
Year
Topic
Type